首页> 美国卫生研究院文献>BMC Nephrology >Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: A randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study)
【2h】

Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: A randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study)

机译:中性粒细胞明胶酶相关脂钙蛋白(NGAL)的早期发现和干预可能会改善急性造影剂诱发的肾病的肾脏预后:接受动脉内血管造影术的患者的一项随机对照试验(ANTI-CIN研究)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPatients with pre-existing impaired renal function are prone to develop acute contrast media induced nephropathy (CIN). Neutrophil gelatinase-associated lipocalin (NGAL), a new biomarker predictive for acute kidney injury (AKI), has been shown to be useful for earlier diagnosis of CIN; however, urinary NGAL values may be markedly increased in chronic renal failure at baseline. Results from those studies suggested that urinary NGAL values may not be helpful for the clinician. An intravenous volume load is a widely accepted prophylactic measure and possibly a reasonable intervention to prevent deterioration of renal function. The aim of our study is to evaluate NGAL as an early predictor of CIN and to investigate the clinical benefit of early post-procedural i.v. hydration.
机译:背景既往存在肾功能受损的患者容易发展为急性造影剂诱发的肾病(CIN)。中性粒细胞明胶酶相关脂质运载蛋白(NGAL)是一种预测急性肾损伤(AKI)的新生物标志物,已被证明可用于CIN的早期诊断。然而,基线时慢性肾功能衰竭时尿NGAL值可能显着增加。这些研究的结果表明,尿NGAL值可能对临床医生没有帮助。静脉容量负荷是被广泛接受的预防措施,并且可能是防止肾功能恶化的合理干预。我们研究的目的是评估NGAL作为CIN的早期预测因子,并研究早期手术后i.v.保湿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号